A new study demonstrates the significant impact of FNIH’s research. The Innovative Medicines Initiative (IMI), a European public-private program working to speed the development of better and safer medicines for patients, released a study commissioned from the independent firm Thomson Reuters that measured how often publications arising from research projects of major biomedical research organizations, such as IMI and FNIH, were cited by others. The five organizations the study compared had a “citation impact” of about twice the world average, “indicating highly-cited internationally significant research.” Among them, the FNIH had the highest percentage—28.8 percent—of highly cited papers. Read the study here.
Donate and Support Today
Take Action to Support Life-Saving Medical Research
Every dollar counts! Your gift to the FNIH makes our efforts possible. With your help—and in partnership with NIH—the Foundation is advancing biomedical research and training.
Donate with Confidence
For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards.
News and Highlights
Inadequate nutrition has been associated with half of deaths worldwide in children under age five. In addition, write investigators from the MAL-ED Network in a special section of the November 1 edition of Clinical Infectious Diseases, the long-term effects of “undernutrition” in young children “have been associated with cognitive and physical growth deficits across multiple generations and have been thought to suppress immunity to further infections and to reduce the efficacy of childhood vaccines. More >>
In 2015, NIH will become one of a select group of institutions of higher learning taking part in the Amgen Scholars Program. ThIs program is made possible by an $850,000 grant to the Foundation for the NIH from the Amgen Foundation. More >>
FNIH is pleased to announce a collaboration with ICON, plc to Develop a New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials.
The National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. More >>